Figures & data
Figure 1. Pharmacotherapy recommendations for the initial treatment of COPD comparing GOLD 2023 and CTS 2023.
Figure 2. Pharmacotherapy recommendations for the follow-up treatment of COPD comparing GOLD 2023 and CTS 2023, when response to the initial treatment is inadequate, for patients with: (A) a dyspnea profile, and (B) An exacerbation profile. Note that the labels “dyspnea profile” and “exacerbation profile” used here for comparative purposes may differ somewhat in definition between the two guidelines.
